University of Connecticut School of Law
State of Connecticut
HONORS AND AWARDS
Chambers USA: America's Leading Lawyers for Business - Healthcare (2017-2019)
Best Lawyers in America® - Biotechnology and Life Sciences Practice; Health Care Law (2005-2020)
BTI Client Service All-Star –
Super Lawyers (2006-2009)
American Bar Association (Business Law, Health Law and Antitrust Law Section)
American Health Lawyers Association
Connecticut Bar Association
Connecticut Health Lawyers Association
Licensing Executives Society
Merton G. Gollaher combines life-science experience with a talent for deal-making to help health care and technology clients compete in ever-changing markets. Trained as a chemist and with years of research experience as a molecular geneticist, Mr. Gollaher utilizes strong analytical thinking to resolve his client’s concerns and help build new affiliations, structure novel delivery networks, and nurture promising startups reshaping how health care is delivered.
Chambers USA described Mr. Gollaher as having a reputation for finding “creative solutions to complex problems.” He puts those skills to work specializing in business transactions, including mergers and acquisitions, affiliations and strategic alliances, financings, and joint ventures, as well as licensing and collaboration arrangements and other technology-transfer matters. He also devotes a significant portion of his practice to cultivating and counseling emerging growth companies spun out of universities and early-, mid-, and late-stage ventures in the biotechnology, life sciences, medical device, and health care IT industries.
Mr. Gollaher clients span a broad spectrum of disciplines, including life sciences, biotechnology, chemical and medical device companies, hospitals, health systems and other health care providers, and IT and manufacturing companies.
Before joining Garfunkel Wild, Mr. Gollaher was a partner at Wiggin and Dana, where he was Chair of the Health Care Transactions Practice Group and Co-Chair of the Academic Medical Centers, Hospitals and Health Systems Practice Group. Prior to that, Mr. Gollaher was a research scientist at Pfizer, engaged in molecular genetics and protein chemistry research and in the application of computer-based modeling and imaging systems to these disciplines.
Mr. Gollaher is listed in The Best Lawyers in America for Health Care Law and Biotechnology, is recognized by Chambers USA as a Leading Lawyer for Business in the health care category, and was recognized as a BTI Consulting Group Client Service All-Star for 2016 and 2017.
Mr. Gollaher received his J.D. with high honors from the University of Connecticut School of Law, where he was on the Connecticut Law Review. He received his B.A. in chemistry from Amherst College.